首页|血清NO、TXB2、ET-1水平与慢性心力衰竭患者NYHA心功能分级、心功能指标的关系及对其预后的预测价值

血清NO、TXB2、ET-1水平与慢性心力衰竭患者NYHA心功能分级、心功能指标的关系及对其预后的预测价值

扫码查看
目的 分析血清一氧化氮(NO)、血栓素B2(TXB2)、内皮素-1(ET-1)水平与慢性心力衰竭(CHF)患者美国纽约心脏病协会(NYHA)心功能分级、心功能指标的关系及对其预后的预测价值.方法 选取2020年8月至2022年8月在该院住院的108例CHF患者作为研究对象,根据NYHA心功能分级标准将患者分为NYHA Ⅱ级组、NYHA Ⅲ级组和NYHA Ⅳ级组.随访1年,根据随访期间患者是否发生严重心律失常、心肌梗死、死亡等不良事件将患者分为预后不良组和预后良好组.采用Pearson相关分析预后不良组CHF患者血清NO、TXB2、ET-1水平与心功能指标的相关性.采用Spearman相关分析CHF患者血清NO、TXB2、ET-1水平与NYHA心功能分级的相关性.采用多因素Logistic回归分析CHF患者预后不良的影响因素.绘制受试者工作特征(ROC)曲线分析血清NO、TXB2、ET-1单独及联合检测对CHF患者预后不良的预测价值.结果 NYHAⅡ级组、Ⅲ级组、Ⅳ级组分别有28、41、39例患者.NYHA Ⅳ级组CHF患者血清NO水平低于NYHA Ⅱ级组、NYHA Ⅲ级组,血清TXB2、ET-1水平高于NYHA Ⅱ级组、NYHA Ⅲ级组,且NYHA Ⅲ级组血清NO水平低于NYHA Ⅱ级组,血清TXB2、ET-1水平高于NYHA Ⅱ级组,差异均有统计学意义(P<0.05).随访期间发生14例严重心律失常、18例心肌梗死、7例死亡.预后不良组和预后良好组分别有39、69例患者.预后不良组左心室舒张末内径(LVEDD)及血清TXB2、ET-1水平均高于预后良好组,左心室射血分数(LVEF)及血清NO水平均低于预后良好组,差异均有统计学意义(P<0.05).Spearman相关分析结果显示,CHF患者血清NO水平与NYHA心功能分级呈负相关(P<0.05),血清TXB2、ET-1水平与NYHA心功能分级呈正相关(P<0.05).Pearson相关分析结果显示,预后不良组CHF患者LVEF与血清NO水平呈正相关(P<0.05),与血清TXB2、ET-1水平呈负相关(P<0.05).预后不良组CHF患者LVEDD与血清NO水平呈负相关,与血清TXB2、ET-1水平呈正相关(P<0.05).多因素Logistic回归分析结果显示,NO>51.02μmol/L 是 CHF 患者预后不良的保护因素(P<0.05),TXB2>130.94 ng/L、ET-1>57.43 ng/L 是 CHF 患者预后不良的危险因素(P<0.05).ROC曲线分析结果显示,血清NO、TXB2、ET-1单独及3项指标联合预测CHF患者预后不良的曲线下面积(AUC)分别为0.858、0.841、0.816、0.963.3项指标联合预测的AUC高于NO、TXB2、ET-1 单独预测的 AUC(Z=2.579、2.638、3.312,P<0.05).结论 血清 NO、TXB2、ET-1 水平与CHF患者NYHA心功能分级、心功能指标有关,可有效预测CHF患者预后不良.
Relationship between serum NO,TXB2,ET-1 levels and NYHA cardiac function grading,cardiac function indicators in patients with chronic heart failure and their predictive value for prognosis
Objective To analyze the relationship between levels of serum nitric oxide(NO),thromboxane B2(TXB2)and endothelin-1(ET-1)and the New York Heart Association(NYHA)cardiac function grading,cardiac function indicators in patients with chronic heart failure(CHF)and their predictive value for progno-sis.Methods A total of 108 patients with CHF admitted to this hospital from August 2020 to August 2022 were selected as the study objects and divided into NYHA Class Ⅱ group,NYHA Class Ⅲ group and NYHA Class Ⅳ group according to the NYHA cardiac function grading criteria.During 1-year follow-up,patients were divided into poor prognosis group and good prognosis group according to whether serious arrhythmia,myocardial infarction,death and other adverse events occurred during the follow-up period.Pearson correlation was used to analyze the correlation between levels of serum NO,TXB2,ET-1 and cardiac function indexes in CHF patients with poor prognosis.Spearman correlation was used to analyze the correlation between levels of serum NO,TXB2,ET-1 and NYHA cardiac function grading in CHF patients.Multivariate Logistic regression was used to analyze the influencing factors of poor prognosis in CHF patients.Receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of serum NO,TXB2 and ET-1 alone and in combina-tion for poor prognosis in patients with CHF.Results There were 28,41 and 39 patients in NYHA Class Ⅱ,Ⅲ and Ⅳ groups respectively.The serum NO level of CHF patients in NYHA Class Ⅳ group was lower than that in NYHA Class Ⅱ group and NYHA Class m group,the serum TXB2 and ET-1 levels in NYHA ClassⅣ group were higher than those in NYHA Class Ⅱ group and NYHA Class Ⅲ group,and the serum NO level in NYHA Class Ⅲ group was lower than that in NYHA Class Ⅱ group,and serum TXB2 and ET-1 levels in NYHA Class Ⅲ group were higher than those in NYHA Class Ⅱ group,and the differences were statistically significant(P<0.05).During the follow-up period,14 cases of severe arrhythmia,18 cases of myocardial in-farction,and 7 cases of death occurred.There were 39 patients in the poor prognosis group and 69 patients in the good prognosis group.The levels of left ventricular end-diastolic diameter(LVEDD)and serum TXB2 and ET-1 in the poor prognosis group were higher than those in the good prognosis group,and the levels of left ventricular ejection fraction(LVEF)and serum NO in the poor prognosis group were lower than those in the good prognosis group,with statistical significance(P<0.05).Spearman correlation analysis showed that ser-um NO level was negatively correlated with NYHA cardiac function grading in CHF patients(P<0.05),and serum TXB2 and ET-1 levels were positively correlated with NYHA cardiac function grading(P<0.05).Pearson correlation analysis showed that LVEF was positively correlated with serum NO level in CHF pa-tients with poor prognosis(P<0.05),and negatively correlated with serum TXB2 and ET-1 levels(P<0.05).There was a negative correlation between LVEDD and serum NO level,and a positive correlation be-tween LVEDD and serum TXB2 and ET-1 level in CHF patients with poor prognosis(P<0.05).Multivariate Logistic regression analysis showed that NO>51.02 μmol/L was a protective factor for poor prognosis in CHF patients(P<0.05),and TXB2>130.94 ng/L and ET-1>57.43 ng/L were risk factors for poor prog-nosis in CHF patients(P<0.05).ROC curve analysis results showed that the area under the curve(AUC)of serum NO,TXB2 and ET-1 alone and combined with the 3 indexes to predict the poor prognosis of CHF pa-tients were 0.858,0.841,0.816 and 0.963 respectively.The AUC predicted by the combination of the 3 indexes was higher than that predicted by NO,TXB2,ET-1 alone(Z=2.579,2.638,3.312;P<0.05).Conclusion Serum levels of NO,TXB2 and ET-1 are related to NYHA cardiac function grading and cardiac function index in CHF patients and can effectively predict the poor prognosis of patients.

chronic heart failurenitric oxidethromboxane B2endothelin-1cardiac function gradingprognosis

朱洪新、金齐颖、任政、苏文静、蒋莹

展开 >

河北省秦皇岛市第二医院心内科,河北秦皇岛 066699

慢性心力衰竭 一氧化氮 血栓素B2 内皮素-1 心功能分级 预后

2025

检验医学与临床
重庆市卫生信息中心 重庆市临床检验中心

检验医学与临床

影响因子:1.096
ISSN:1672-9455
年,卷(期):2025.22(1)